Alebund Pharmaceuticals Raises $60 Million In Series B Financing Round To Accelerate Its Development Of Innovative Drugs And Total Solutions For The Treatment Of Renal Diseases
Amount Raised
$60 Million
Round Type
Series B
ShanghaiBiotechnologyHealth CarePharmaceuticalDescription
Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised $60 million in its Series B financing round which was led by Quan Capital, and followed by a prominent sovereign wealth fund, 3E Bioventures Capital, and Sherpa Healthcare Partners. Existing Shareholders, Lilly Asia Ventures and Med-Fine Capital, also took part in this financing round. Proceeds raised from this round will be invested in the research and development of pre-clinical assets, clinical programs, the construction of the manufacturing site, and the expansion of Company's talent pool.
Quick answer
Alebund Pharmaceutical raised $60 Million in a Series B round, dated May 10, 2021. Alebund Pharmaceutical is based in Shanghai, Shanghai, China.
- How much did Alebund Pharmaceutical raise?
- Alebund Pharmaceutical raised $60 Million in a Series B round on May 10, 2021.
- What does Alebund Pharmaceutical do?
- Alebund was incubated in Shanghai in 2018.
- Where is Alebund Pharmaceutical based and how big is it?
- Alebund Pharmaceutical is based in Shanghai, Shanghai, China. Fundz records about 3 employees.
- Who are the decision-makers at Alebund Pharmaceutical?
- Fundz holds 1 contact at Alebund Pharmaceutical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as Alebund Pharmaceutical that raised within 45 days of this round, from Fundz verified event records.
- Arbutus raised $81M on June 23, 2021.
- Zevra Therapeutics, Inc. raised $39M on June 22, 2021.
- Ajax Therapeutics, Inc. raised $37M on June 1, 2021.
- Harrow raised $11M on May 14, 2021.
- Nuvalent raised $135M on May 12, 2021.
- Nuvalent raised $135M (Series B) on May 11, 2021.
Who to call at Alebund Pharmaceutical, and when
A new round usually means Alebund Pharmaceutical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alebund Pharmaceutical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alebund Pharmaceutical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alebund Pharmaceutical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alebund Pharmaceutical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAlebund Pharmaceutical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.